Company Filing History:
Years Active: 2018-2021
Title: Weiqun Li: Innovator in Cancer Treatment
Introduction
Weiqun Li is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Li's work focuses on enhancing the efficacy of cancer therapies.
Latest Patents
One of Weiqun Li's latest patents is titled "Compositions and methods for inhibiting arginase activity." This invention relates to methods of treating cancer by utilizing a combination of an arginase inhibitor and a chemotherapeutic agent. Furthermore, it includes methods for assessing the efficacy of cancer treatment by measuring arginine levels in a tumor. This innovative approach aims to improve treatment outcomes for cancer patients.
Career Highlights
Weiqun Li is currently associated with Calithera Biosciences, Inc., where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to revolutionize treatment methodologies in oncology.
Collaborations
Li collaborates with esteemed colleagues, including Matthew I Gross and Susanne M Steggerda, who contribute to the innovative environment at Calithera Biosciences, Inc. Their combined expertise fosters a collaborative approach to tackling complex challenges in cancer treatment.
Conclusion
Weiqun Li's contributions to cancer treatment through his patented inventions highlight his role as a leading innovator in the field. His work not only advances scientific understanding but also holds promise for improving patient care in oncology.